# An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Study · id `cardio:ct-nct02235909` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02235909](<https://clinicaltrials.gov/study/NCT02235909>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02235909

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 377 participants.

## Technical summary

Registry record NCT02235909. Randomized; triple masking; primary purpose treatment. Start 2015-03-30 (actual); primary completion 2019-11-11 (actual). Results posted on 2025-02-25.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 377 participants (enrolled count; ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Started: 2015-03-30 (actual) (ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Primary completion: 2019-11-11 (actual) (ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Completion: 2019-11-11 (actual) (ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Results first posted: 2025-02-25 (ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Countries: United States; Argentina; Brazil; Bulgaria; Colombia; Hungary; Italy; Mexico; Poland; South Africa; Türkiye; Ukraine (ClinicalTrials.gov record NCT02235909, source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02235909-2025-02-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
- Condition: Hypertension
- Intervention (Drug): Azilsartan Medoxomil Low-dose
- Intervention (Drug): Losartan
- Intervention (Drug): Placebo for Azilsartan Medoxomil
- Intervention (Drug): Placebo for Losartan
- Intervention (Drug): Azilsartan Medoxomil Medium-dose (20 mg)
- Intervention (Drug): Azilsartan Medoxomil High-dose (40 mg)
- Lead sponsor: Arbor Pharmaceuticals, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Losartan (`cardio:losartan`)

## Provenance

Content hash: 4848358c5a7a6ad5d3b285ecc5a43ca912bb4dbde9cb54681422c15405266f39
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
